473 related articles for article (PubMed ID: 27914922)
21. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
Wu C; Khan SA; Peng LJ; Li H; Carmella SG; Lange AJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E536-43. PubMed ID: 16621898
[TBL] [Abstract][Full Text] [Related]
22. Palmitate-induced insulin resistance is attenuated by Pioglitazone and EGCG through reducing the gluconeogenic key enzymes expression in HepG2 cells.
Yadollah S; Kazemipour N; Bakhtiyari S; Nazifi S
J Med Life; 2017; 10(4):244-249. PubMed ID: 29362600
[TBL] [Abstract][Full Text] [Related]
23. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.
Doi M; Yamaoka I; Nakayama M; Sugahara K; Yoshizawa F
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1683-93. PubMed ID: 17299083
[TBL] [Abstract][Full Text] [Related]
24. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.
Andreelli F; Foretz M; Knauf C; Cani PD; Perrin C; Iglesias MA; Pillot B; Bado A; Tronche F; Mithieux G; Vaulont S; Burcelin R; Viollet B
Endocrinology; 2006 May; 147(5):2432-41. PubMed ID: 16455782
[TBL] [Abstract][Full Text] [Related]
25. Phenobarbital reduces blood glucose and gluconeogenesis through down-regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression in rats.
Oda H; Okuda Y; Yoshida Y; Kimura N; Kakinuma A
Biochem Biophys Res Commun; 2015 Oct; 466(3):306-11. PubMed ID: 26348778
[TBL] [Abstract][Full Text] [Related]
26. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
[TBL] [Abstract][Full Text] [Related]
27. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism.
Davies GF; Khandelwal RL; Roesler WJ
Biochim Biophys Acta; 1999 Aug; 1451(1):122-31. PubMed ID: 10446394
[TBL] [Abstract][Full Text] [Related]
28. Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.
Chanda D; Kim SJ; Lee IK; Shong M; Choi HS
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E368-79. PubMed ID: 18505831
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice.
Meng R; Zhu D; Bi Y; Yang D; Wang Y
PLoS One; 2013; 8(1):e53557. PubMed ID: 23326455
[TBL] [Abstract][Full Text] [Related]
30. Effects of oolong tea on gene expression of gluconeogenic enzymes in the mouse liver and in rat hepatoma H4IIE cells.
Yasui K; Miyoshi N; Tababe H; Ishigami Y; Fukutomi R; Imai S; Isemura M
J Med Food; 2011 Sep; 14(9):930-8. PubMed ID: 21812644
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Activating Transcription Factor 4 (ATF4) Expression by Fat Mass and Obesity-Associated (FTO) in Mouse Hepatocyte Cells.
Mizuno TM; Lew PS
Acta Endocrinol (Buchar); 2021; 17(1):26-32. PubMed ID: 34539907
[TBL] [Abstract][Full Text] [Related]
32. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
Cai H; Jiang Z; Yang X; Lin J; Cai Q; Li X
Endocr J; 2020 Apr; 67(4):397-408. PubMed ID: 31875589
[TBL] [Abstract][Full Text] [Related]
33. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.
Laffitte BA; Chao LC; Li J; Walczak R; Hummasti S; Joseph SB; Castrillo A; Wilpitz DC; Mangelsdorf DJ; Collins JL; Saez E; Tontonoz P
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5419-24. PubMed ID: 12697904
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.
Alberts P; Nilsson C; Selen G; Engblom LO; Edling NH; Norling S; Klingström G; Larsson C; Forsgren M; Ashkzari M; Nilsson CE; Fiedler M; Bergqvist E; Ohman B; Björkstrand E; Abrahmsen LB
Endocrinology; 2003 Nov; 144(11):4755-62. PubMed ID: 12960099
[TBL] [Abstract][Full Text] [Related]
35. Control of gluconeogenic genes during intense/prolonged exercise: hormone-independent effect of muscle-derived IL-6 on hepatic tissue and PEPCK mRNA.
Banzet S; Koulmann N; Simler N; Sanchez H; Chapot R; Serrurier B; Peinnequin A; Bigard X
J Appl Physiol (1985); 2009 Dec; 107(6):1830-9. PubMed ID: 19850730
[TBL] [Abstract][Full Text] [Related]
36. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM
Nature; 2001 Sep; 413(6852):131-8. PubMed ID: 11557972
[TBL] [Abstract][Full Text] [Related]
37. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
[TBL] [Abstract][Full Text] [Related]
38. [Novel aspects in the mechanisms of steroid diabetes and the regulation of hepatic glucose production by insulin and steroids].
Barthel A; Scherbaum WA; Bornstein SR
Med Klin (Munich); 2003 Apr; 98(5):283-6. PubMed ID: 12721674
[TBL] [Abstract][Full Text] [Related]
39. PEPCK-M expression in mouse liver potentiates, not replaces, PEPCK-C mediated gluconeogenesis.
Méndez-Lucas A; Duarte JA; Sunny NE; Satapati S; He T; Fu X; Bermúdez J; Burgess SC; Perales JC
J Hepatol; 2013 Jul; 59(1):105-13. PubMed ID: 23466304
[TBL] [Abstract][Full Text] [Related]
40. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
